Referencias:

• Acosta, E.G., Bruttomesso, A.C., Bisceglia, J.A., Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro (2008) Virus Res, 135, pp. 203-212
• Araghi-Niknam, M., Liang, B., Zhang, Z., Modulation of immune dysfunction during murine leukaemia retrovirus infection in old mice by dehyroepiandrosterone sulphate (DHEAS) (1997) Immunology, 90, pp. 344-349
• Ben-Nathan, D., Lachmi, B., Lustig, S., Protection by dehydroepiandrosterone in mice infected with viral encephalitis (1991) Arch Virol, 120, pp. 263-271
• Benz, D., Cadet, P., Mantione, K., Tonal nitric oxide and health: Anti-bacterial and-viral actions and implications for HIV (2002) Med Sci Monit, 8, pp. RA27-RA31
• Bradley, W., Graus, L., Good, R., Dehydroepiandrosterone inhibits replication of feline immunodeficiency virus in chronically infected cells (1995) Vet Immunol Immunopathol, 46, pp. 159-168
• Castilla, V., Larzábal, M., Sgalippa, N.A., Antiviral mode of action of a synthetic brassinosteroid against Junin virus replication (2005) Antiviral Res, 68, pp. 88-95
• Castilla, V., Ramírez, J.A., Coto, C.E., Plant and animal steroids a new hope to search for antiviral agents (2010) Curr Med Chem, 17, pp. 1858-1873
• Chang, C., Ou, Y., Raung, S., Chen, C., Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection (2005) J Gen Virol, 86, pp. 2513-2523
• De Clercq, E., Highlights in the discovery of antiviral drugs: A personal retrospective (2010) J Med Chem, 53, pp. 1438-1450
• Esté, J.A., Cihlar, T., Current status and challenges of antiretroviral research and therapy (2010) Antiviral Res, 85, pp. 25-33
• Henderson, E., Schwartz, A., Pashko, L., Dehydroepiandrosterone and 16 alpha-bromo-epiandrosterone: Inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes (1981) Carcinogenesis, 2, pp. 683-686
• Henderson, E., Yang, J.Y., Schwartz, A., Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication (1992) AIDS Res Hum Retroviruses, 8, pp. 625-631
• Jacobson, M.A., Fusaro, R.E., Galmarini, M., Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499 (1991) J Infect Dis, 164, pp. 864-868
• Jiang, Y., Miyazaki, T., Honda, A., Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandreosterone (2005) J Gastoenterol, 40, pp. 460-497
• Labrie, F., Luu-The, V., Labrie, C., Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) Endocr Rev, 24, pp. 152-182
• Linero, F.N., Scolaro, L.A., Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junin virus replication in vitro (2009) Virus Res, 145, pp. 166-170
• Loria, R.M., Inge, T.H., Cook, S.S., Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA) (1988) J Med Virol, 26, pp. 301-314
• Mavoungou, D., Poaty-Mavoungoun, V., Akoume, M., Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein mediated cell-cell fusion by immunor (IM28) (2005) Virol J, 2, pp. 2-9
• Mulder, J.W., Frissen, P.H., Krijnen, P., Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men (1992) J Inf Dis, 165, pp. 413-418
• Nishimura, T., Seki, Y., Sato, K., Enhancement of zidovudine uptake by dehydroepiandrosterone sulfate in rat syncytiotrophoblast cell line TR-TBT 18d-1 (2008) Drug Metab Dispos, 36, pp. 2080-2085
• Pedersen, N.C., North, T.W., Rigg, R., 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: Initial enhancement leading to long-term suppression (2003) Vet Immunol Immunopathol, 94, pp. 133-148
• Romanutti, C., Bruttomesso, A.C., Castilla, V., In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus (2009) Vet J, 182, pp. 327-335
• Romanutti, C., Bruttomesso, A.C., Castilla, V., Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives (2010) Chemotherapy, 56, pp. 158-165
• Romanutti, C., Castilla, V., Coto, C.E., Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells (2007) Int J Antimicrob Agents, 29, pp. 311-316
• Schümann, M., Dobbelstein, M., Adenovirus induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny (2006) Cancer Res, 66, pp. 1282-1288
• Shin, Y., Liu, Q., Tikoo, S.K., Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza a virus propagation (2007) J Gen Virol, 88, pp. 942-950
• Simoncini, T., Mannella, P., Fornari, L., Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms (2003) Endocrinology, 144, pp. 3449-3455
• Wachsman, M.B., Ramírez, J.A., Talarico, L.B., Antiviral activity of natural and synthetic brassinosteroids (2004) Curr Med Chem-Anti-Infective Agents, 3, pp. 163-179
• Whiting, K.P., Restall, C.J., Brain, P.F., Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms (2000) Life Sci, 7, pp. 743-757
• Yang, J.Y., Schwartz, A., Henderson, E.E., Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA (1993) AIDS Res Hum Retroviruses, 9, pp. 747-754
• Yang, J.Y., Schwartz, A., Henderson, E.E., Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro (1994) Biochem Biophys Res Commun, 201, pp. 1424-1432
• Zhang, Z., Araghi-Niknam, M., Liang, B., Prevention of immune dysfunction and vitamin E loss by dehydrepiandrosterone and melatonin supplementation during murine retrovirus infection (1999) Immmunology, 96, pp. 291-297

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------